Abstract
Two monoclonal antibodies, M-L25 and M-L47, were produced against the human lymphoid Fc receptor for IgE (FcεR). These antibodies were identified by their ability to selectively inhibit the binding of IgE to FcεR+ lymphoid cells as demonstrated by a newly developed IgE rosetting assay. In this method, NIP coated ox erythrocytes were complexed with a NP-specific recombinant chimeric human/mouse IgE antibody and employed as indicator cells for the detection of FcεR+ cells. The anti-FcεR antibodies stained 4.6 ± 2.3% of normal peripheral blood mononuclear cells, 0-4 ± 0.3% of T cells, 22.2 ± 11.7% of the non-T cell fraction, and 34.9 ± 2.9% of tonsil cells. Less than 0.1% of monocytes, basophilic and eosinophilic granulocytes, platelets, and thymus cells were labelled. This indicates an antigenic heterogeneity of the low affinity FcεR on lymphocytes and the FcεR found on monocytes, platelets, and eosinophilic granulocytes. The lymphoid FcεR was immunoprecipitated by M-L25 from the lysate of surface iodinated lymphoid cells. Three polypeptide chains were identified having an apparent MW of 40, 82, and 100 kd under non-reducing, and of 42, 115, and 145 kd under reducing conditions, suggesting a multichain structure of the human lymphoid FcεR.
Get full access to this article
View all access options for this article.
